PKD1 alleviates oxidative stress‐inhibited osteogenesis of rat bone marrow‐derived mesenchymal stem cells through TAZ activation

Oxidative stress is known to inhibit osteogenesis and PKD1 is implicated in bone remodeling and skeletogenesis. In the present study, we explored the role of PKD1 in osteogenesis under oxidative stress. H(2)O(2) was used to induce oxidative stress in rat bone marrow (BM)‐mesenchymal stem cells (MSCs) during osteoblast differentiation. Alkaline phosphatase (ALP) activity, calcium deposits, and the RUNX2 marker were assayed to determine osteogenic differentiation. The correlation of PKD1, Sirt1, c‐MYC, and TAZ was further confirmed by chromatin immunoprecipitation (ChIP) and dual‐luciferase reporter assay. We found that H(2)O(2) induced the downregulation of PKD1 expression and the upregulation of c‐MYC, and Sirt1 was accompanied by decreasing cell viability in BM‐MSCs. During osteogenic differentiation, the expression of PKD1 was upregulated significantly whereas Sirt1 tended to be upregulated mildly under normal conditions. Both PKD1 and Sirt1 were upregulated upon oxidative stress. The positive correlation of PKD1 expression with osteogenic differentiation under normal conditions might be hindered by oxidative stress and PKD1 could interact with TAZ under oxidative stress to regulate osteogenic differentiation. Our results suggest that PKD1 may alleviate oxidative stress‐inhibited osteogenesis of rat BM‐MSCs through TAZ activation.